80 related articles for article (PubMed ID: 809050)
1. Responses of an experimental solid tumour to irradiation: A comparison of modes of fractionation.
Schenken LL; Poulakos L; Hagemann RF
Br J Cancer; 1975 Feb; 31(2):228-36. PubMed ID: 809050
[TBL] [Abstract][Full Text] [Related]
2. Combined-modality oncotherapy with cyclophosphamide (NSC-26271) and radiotherapy: control of murine mastocytoma.
Schenken LL; Hagemann RF; Burholt DR; Lesher S
J Natl Cancer Inst; 1976 Oct; 57(4):943-9. PubMed ID: 826650
[TBL] [Abstract][Full Text] [Related]
3. Treatment of solid P815x2 murine mastocytoma with adriamycin (NSC-1231127): toxity limitations.
Schenken LL; Poulakos L; Hagemann RF; Burholt D; Lesher S
J Natl Cancer Inst; 1976 Mar; 56(3):683-5. PubMed ID: 815561
[TBL] [Abstract][Full Text] [Related]
4. Control of local tumor growth with combined fractionated radiotherapeutic and chemotherapeutic regimens.
Poulakos L; Schenken LL; Hagemann RF; Burholt DR; Lesher S
J Natl Cancer Inst; 1975 May; 54(5):1103-5. PubMed ID: 805253
[TBL] [Abstract][Full Text] [Related]
5. Solid tumor models for the assessment of different treatment modalities: XXIII. A new approach to the more effective utilization of radiotherapy alternated with chemotherapy.
Looney WB; Hopkins HA; Carter WH
Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2105-17. PubMed ID: 4066443
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of 5-hydroxyindoles as an indicator of in vivo growth of P815X2 mastocytoma.
Raikow RB; Schenken LL; Lesher S
Eur J Cancer (1965); 1976 Dec; 12(12):1011-5. PubMed ID: 827448
[No Abstract] [Full Text] [Related]
7. Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159.
Peters LJ
Br J Radiol; 1976 Aug; 49(584):708-15. PubMed ID: 953390
[TBL] [Abstract][Full Text] [Related]
8. Prospective studies with the CRE formula of prolonged fractionation schedules.
Notter G; Turesson I
Radiology; 1976 Dec; 121(3 Pt. 1):709-15. PubMed ID: 981673
[TBL] [Abstract][Full Text] [Related]
9. The effect of mixed fractionation with X rays and neutrons on tumour growth delay and skin reactions in mice.
Carl UM; McNally NJ; Joiner MC
Br J Radiol; 1987 Jun; 60(714):583-8. PubMed ID: 3620817
[TBL] [Abstract][Full Text] [Related]
10. The response of mouse tumours to fractionated doses of pions: determination of therapeutic gain factor.
Ogawa Y; Goodman GB; Chaplin DJ; Grulkey W; Lam GK
Oncology; 1991; 48(1):81-7. PubMed ID: 1987502
[TBL] [Abstract][Full Text] [Related]
11. Some aspects of the chronological dose distribution in the radiobiology and radiotherapy.
Ulmer W
Strahlenther Onkol; 1986 Jun; 162(6):374-86. PubMed ID: 3738738
[TBL] [Abstract][Full Text] [Related]
12. Probing spatiotemporal fractionation on the preclinical level.
Telarovic I; Krayenbuehl J; Grgic I; Tschanz F; Guckenberger M; Pruschy M; Unkelbach J
Phys Med Biol; 2020 Nov; 65(22):22NT02. PubMed ID: 33179609
[TBL] [Abstract][Full Text] [Related]
13. Misonidazole with small dose fractions in an experimental osteosarcoma.
van Putten LM; Smink T
Br J Cancer Suppl; 1978 Jun; 3():246-9. PubMed ID: 277240
[TBL] [Abstract][Full Text] [Related]
14. An historical survey of radiobiology and radiotherapy with fast neutrons.
Field SB
Curr Top Radiat Res Q; 1976 Jan; 11(1):1-86. PubMed ID: 1106959
[TBL] [Abstract][Full Text] [Related]
15. Different fractionation schemes tested by histological examination of autopsy specimens from lung cancer patients.
Eichhorn HJ
Br J Radiol; 1981 Feb; 54(638):132-5. PubMed ID: 7459551
[TBL] [Abstract][Full Text] [Related]
16. Optimum overall times II: Extended modelling for head and neck radiotherapy.
Fowler JF
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):113-26. PubMed ID: 18155893
[TBL] [Abstract][Full Text] [Related]
17. Acute normal tissue tolerance to 7 day per week accelerated fractionation.
Lipsett JA; Desai K; Pezner R; Vora N; Chong LM; Archambeau JO
Int J Radiat Oncol Biol Phys; 1984 Jul; 10(7):1049-52. PubMed ID: 6746345
[TBL] [Abstract][Full Text] [Related]
18. A low dose-fractionation shceme for the radiotherapy of carcinoma of the bladder. Experimental background and preliminary results.
Littbrand B; Edsmyr F; Révész L
Bull Cancer; 1975; 62(3):241-8. PubMed ID: 1191783
[TBL] [Abstract][Full Text] [Related]
19. Dose fractionation schedules--biologic aspects and applications to high LET radiotherapy.
Fowler JF
J Can Assoc Radiol; 1975 Mar; 26(1):40-3. PubMed ID: 806599
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results using twice-a-day fractionation in the radiotherapeutic management of advanced cancers of the head and neck.
Jampolis S; Pipard G; Horiot JC; Bolla M; Le Dorze C
AJR Am J Roentgenol; 1977 Dec; 129(6):1091-3. PubMed ID: 413365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
